Epidemiology of basal and squamous cell carcinoma in Belgium: the need for a uniform and compulsory registration

Journal of the European Academy of Dermatology and Venereology

Volumn 30, Issue 11, 2016, Pages 1912-1918

  Callens, J ^a   Van Eycken, L ^b   Henau, K ^b   Garmyn, M ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b Belgian Cancer Registry   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; BASAL CELL CARCINOMA; BELGIUM; CANCER INCIDENCE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; AGED; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; INCIDENCE; SKIN NEOPLASMS;

AGED; BELGIUM; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; HUMANS; INCIDENCE; SKIN NEOPLASMS;

EID: 84973363520     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.13703     Document Type: Article

References (44)

1. De Vries E, van de Poll-Franse LV, Louwman WJ et al. Predictions of skin cancer incidence in the Netherlands up to 2015. Br J Dermatol 2005; 152: 481–488.
2. Carsin AE, Sharp L, Comber H. Geographical, urban/rural and socioeconomic variations in nonmelanoma skin cancer incidence: a population-based study in Ireland. Br J Dermatol 2011; 164: 822–829.
3. Jurciukonyte R, Vincerzevskiene I, Krilaviciute A et al. Epidemiology of basal cell carcinoma in Lithuania, 1996-2010. Br J Dermatol 2013; 169: 1100–1105.
4. Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012; 166: 1069–1080.
5. Flohil SC, Seubring I, van Rossum MM et al. Trends in basal cell carcinoma incidence rates: a 37-year Dutch observational study. J Invest Dermatol 2013; 133: 913–918.
6. Puig S, Berrocal A. Management of high-risk and advanced basal cell carcinoma. Clin Transl Oncol 2015; 17: 497–503.
7. Von Domarus H, Stevens PJ. Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol 1984; 10: 1043–1060.
8. Karia PS, Han J, Schmults CD. Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. J Am Acad Dermatol 2013; 68: 957–966.
9. Katalinic A, Kunze U, Schäfer T. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Br J Dermatol 2003; 149: 1200–1206.
10. Birch-Johansen F, Jensen A, Mortensen L et al. Trends in the incidence of nonmelanoma skin cancer in Denmark 1978–2007: rapid incidence increase among young Danish women. Int J Cancer 2010; 127: 2190–2198.
11. Belgian Cancer Registry. Cancer Incidence in Belgium, 2010. Brussels, 2013. Available at http://www.belgiancancerregistry.be/Publications.
12. Belgian Cancer Registry. Cancer Incidence in Belgium, 2008. Brussels, 2011. Available at http://www.belgiancancerregistry.be/Publications.
13. Henau K, Van Eycken E, Silversmit G, Pukkala E. Regional variation in incidence for smoking and alcohol related cancers in Belgium. Cancer Epidemiol 2015; 39: 55–65.
14. Belgian Cancer Registry. Cancer Incidence in Belgium, 2012. Brussels, 2014. Available at http://www.belgiancancerregistry.be/AnnualTables (last accessed: 8 October 2015).
15. Directorate-general statistics Belgium and Economic Information, Federal public service economy. SMEs, self-employed and energy. http://statbel.fgov.be/nl/modules/publications/statistiques/bevolking/bevolking_-_cijfers_bevolking_2010_-_2012.jsp (last accessed: 8 October 2015).
16. CODAP. Code voor Histopathologische Diagnosen. Stichting Kankerregister en Belgische beroepsvereniging der geneesheren-specialisten in de Pathologische Anatomie, Brussels, 2007.
17. Côté RA, Rothwell DJ, Palotay JL et al. The Systematized Nomenclature of Human and Veterinary Medicine. SNOMED International, Vol. 1. College of American Pathologists, Northfield, IL, 1993.
18. Fritz A, Percy C, Jack A et al. International Classification of Diseases for Oncology (ICD-0), 3rd edn. World Health Organization, Geneva, 2000.
19. World Health Organization. International Classification of Diseases and Related Health Problems, 10th revision. World Health Organization, Geneva, 1992.
20. Parkin DM, Chen VW, Ferlay J et al. Comparability and quality control in cancer registration. IARC technical report No. 19. International Agency for Research on Cancer, Lyon, 1994.
21. Levi F, Te VC, Randimbison L et al. Trends in skin cancer incidence in Vaud: an update, 1976-1998. Eur J Cancer Prev 2001; 10: 371–373.
22. Stang A, Ziegler S, Büchner U et al. Malignant melanoma and nonmelanoma skin cancers in NorthRhine – Westphalia, Germany: a patient – vs diagnosis-based incidence approach. Int J Dermatol 2007; 46: 564–570.
23. Madan V, Lear JT, Szeimies RM. Non-melanoma skin cancer. Lancet 2010; 375: 673–685.
24. Clegg LX, Hankey BF, Tiwari R et al. Estimating average annual percent change in trend analysis. Stat Med 2009; 28: 3670–3682.
25. National Cancer Institute. Joinpoint Regression Program, Version 4.1.1.1 - October 2014. Statistical Methodology and Applications Branch, Surveillance Research Program.
26. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with application to cancer rates. Stat Med 2000; 19: 335–351.
27. Belgian Cancer Registry. Cancer Incidence in Belgium, 2012: haematological malignancies. Brussels, 2014. Available at http://www.belgiancancerregistry.be/Publications.
28. Musah A, Gibson JE, Leonardi-Bee J et al. Regional variations of basal cell carcinoma incidence in the U.K. using The Health Improvement Network database (2004-10). Br J Dermatol 2013; 169: 1093–1099.
29. Hollestein LM, de Vries E, Nijsten T. Trends of cutaneous squamous cell carcinoma in the Netherlands: increased incidence rates, but stable relative survival and mortality 1989-2008. Eur J Cancer 2012; 48: 2046–2053.
30. Leiter U, Eigentler T, Garbe C. Epidemiology of skin cancer. Adv Exp Med Biol 2014; 810: 120–140.
31. Holterhues C, de Vries E, Louwman MW et al. Incidence and trends of cutaneous malignancies in the Netherlands, 1989-2005. J Invest Dermatol 2010; 130: 1807–1812.
32. Reinau D, Surber C, Jick SS, Meier CR. Epidemiology of basal cell carcinoma in the United Kingdom: incidence, lifestyle factors and comorbidities. Br J Cancer 2014; 111: 203–206.
33. Brewster DH, Bhatti LA, Inglis JH et al. Recent trends in incidence in nonmelanoma skin cancers in the East of Scotland, 1992–2003. Br J Dermatol 2007; 156: 1295–1300.
34. Stang A, Stegmaier C, Jöckel KH. Nonmelanoma skin cancer in the Federal state of Saarland, Germany, 1995–1999. Br J Cancer 2003; 89: 1205–1208.
35. Buettner PG, Raasch BA. Incidence rates of skin cancer in Townsville, Australia. Int J Cancer 1998; 78: 587–593.
36. Levell NJ, Igali L, Wright KA, Greenberg DC. Basal cell carcinoma epidemiology in the UK: the elephant in the room. Clin Exp Dermatol 2013; 38: 367–369.
37. Van der Geer S, Siemerink M, Reijers HA et al. The incidence of skin cancer in dermatology. Clin Exp Dermatol 2013; 38: 724–729.
38. Osterlind A, Hou-Jensen K, Moller Jensen O. Incidence of cutaneous malignant melanoma in Denmark 1978–1982. Anatomic site distribution, histologic types, and comparison with non-melanoma skin cancer. Br J Cancer 1988; 58: 385–391.
39. Hannuksela-Svahn A, Pukkala E, Karvonen J. Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995. Arch Dermatol 1999; 135: 781–786.
40. Holme SA, Malinovszky K, Roberts DL. Changing trends in non-melanoma skin cancer in South Wales, 1988–1998. Br J Dermatol 2000; 143: 1224–1229.
41. Hussain SK, Sundquist J, Hemminki K. Incidence trends of squamous cell and rare skin cancers in the Swedish national cancer registry point to calendar year and age-dependent increases. J Invest Dermatol 2010; 130: 1323–1328.
42. Harris RB, Griffith K, Moon TE. Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985-1996. J Am Acad Dermatol 2001; 45: 528–536.
43. Staples MP, Elwood M, Burton RC et al. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust 2006; 184: 6–10.
44. Bath-Hextall F, Leonardi-Bee J, Smith C et al. Trends in incidence of skin basal cell carcinoma. Additional evidence from a UK primary care database study. Int J Cancer 2007; 121: 2105–8.